Canada markets closed

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.57+0.48 (+6.77%)
At close: 04:00PM EDT
7.36 -0.21 (-2.77%)
After hours: 04:42PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
15,411
15,411
26,214
23,322
9,342
Selling General and Administrative
24,864
24,864
18,921
12,350
2,425
Total Operating Expenses
40,275
40,275
45,135
35,672
11,767
Operating Income or Loss
-40,275
-40,275
-45,135
-35,672
-11,767
Total Other Income/Expenses Net
536
536
-1,484
-11,808
-8,901
Income Before Tax
-35,119
-35,119
-45,244
-47,480
-20,668
Income from Continuing Operations
-35,119
-35,119
-45,244
-47,480
-20,668
Net Income
-35,119
-35,119
-45,244
-47,480
-20,668
Net Income available to common shareholders
-35,119
-35,119
-45,244
-52,028
-22,953
Basic EPS
-1.46
-
-1.72
-4.24
-1.97
Diluted EPS
-1.46
-
-1.72
-4.24
-1.97
Basic Average Shares
26,696
-
26,312
12,261
11,662
Diluted Average Shares
26,696
-
26,312
12,261
11,662